Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers

Chinese Medical Journal

Volumn 122, Issue 15, 2009, Pages 1749-1754

  Liu, Bao Jun ^a   Dong, Jing Cheng ^a   Xu, Chang Qing ^a   Zuo, Chuan Tao ^a   Le, Jing Jing ^a   Guan, Yi Hui ^a   Zhao, Jun ^a   Wu, Jin Feng ^a   Duan, Xiao Hong ^a   Cao, Yu Xue ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Lymph node metastasis; Non small cell lung cancer; Radiography; Tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM METASTASIS; PREDICTION; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR VOLUME; LUNG TUMOR; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 70349556276     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.15.006     Document Type: Article

References (21)

1. Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 2008; 33: 104-109.
2. Meyer A, Cheng C, Antonescu C, Pezzetta E, Bischof-Delaloye A, Ris HB. Successful migration of three tracers without identification of sentinel nodes during intraoperative lymphatic mapping for non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2007; 6: 214-218.
3. An YS, Sun JS, Park KJ, Hwang SC, Sheen SS, Lee S, et al. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. Lung 2008; 186: 327-336.
4. Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. Lung Cancer 2008; 60: 62-68.
5. Dimitrakopoulou-Strauss A, Hoffmann M, Bergner R, Uppenkamp M, Eisenhut M, Pan L. Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-Dglucose-positron emission tomography: a feasibility study. Mol Imaging Biol 2007; 9: 308-317.
6. Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 2003; 70: 500-506.
7. Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT - a prospective study. Radiology 2006; 241: 501-509.
8. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, et al. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000; 55: 317-324.
9. Seemann MD, Schaefer JF, Englmeier KH. Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application. Eur Radiol 2007; 17: 709-715.
10. Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, et al. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 2007; 48: 1761-1766.
11. Ebihara A, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Uno K, et al. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients. Jpn J Clin Oncol 2006; 36: 694-698.
12. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-1723.
13. Yamamoto Y, Nishiyama Y, Kimura N, Ishikawa S, Okuda M, Bandoh S, et al. Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2008; 35: 236-245.
14. Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 2004; 125: 2300-2308.
15. De Wever W, Vankan Y, Stroobants S, Verschakelen J. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007; 29: 995-1002.
16. Yang W, Fu Z, Yu J, Yuan S, Zhang B, Li D, et al. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Lung Cancer 2008; 61: 35-43.
17. de Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 2006; 29: 26-29.
18. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 2004; 9: 633-643.
19. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 2005; 47: 235-242.
20. Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 2008; 248: 632-642.
21. Guan ZW, Yao SL, Tian JH. The dianosis of pulmonary neoplasms with standard uptake value and its sensitivity analysis. J China Clin Med Imaging (Chin) 2003: 3: 169-172.